Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127913991 | 12791399 | 1 | I | 20160922 | 20160929 | 20160929 | EXP | PHHY2016CA131488 | NOVARTIS | 0.00 | M | Y | 0.00000 | 20160929 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127913991 | 12791399 | 1 | PS | GLEEVEC | IMATINIB MESYLATE | 1 | Oral | 200 MG, QD | 21588 | 200 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127913991 | 12791399 | 1 | Gastrointestinal stromal tumour |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127913991 | 12791399 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127913991 | 12791399 | Aphasia | |
| 127913991 | 12791399 | Asthenia | |
| 127913991 | 12791399 | Dysphagia | |
| 127913991 | 12791399 | General physical health deterioration | |
| 127913991 | 12791399 | Oral discomfort | |
| 127913991 | 12791399 | Oral mucosal exfoliation | |
| 127913991 | 12791399 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127913991 | 12791399 | 1 | 201608 | 0 |